Monique Mols

Public Communications Contact presso ASML HOLDING N.V.

Electronic Technology

Health Technology

Profilo

Monique Mols is currently working as the Head-Media Relations at ASML Holding NV since 2012.
Prior to this, she worked as the Director-Media Relations at Organon NV from 2002 to 2007.

Posizioni attive di Monique Mols

Società	Posizione	Inizio
ASML HOLDING N.V.	Public Communications Contact	01/12/2012

Tutte le posizioni attive di Monique Mols

Precedenti posizioni note di Monique Mols

Società	Posizione	Fine
Organon NV Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands.	Investor Relations Contact	01/11/2007

Vedi nel dettaglio l'esperienza di Monique Mols

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Monique Mols

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
ASML HOLDING N.V.	Electronic Technology

Aziende private	1
Organon NV Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands.	Health Technology